Innovative medicine : basic research and development /
Saved in:
Meeting name: | Uehara Memorial Foundation Symposium (2014 : Tokyo, Japan) |
---|---|
Imprint: | Tokyo : SpringerOpen, [2015] ©2015 |
Description: | 1 online resource (ix, 339 pages) : illustrations |
Language: | English |
Series: | Online access with purchase: Springer. |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11097125 |
Table of Contents:
- Part I: Basic research for innovative medicine. Diverting Glycolysis to Combat Oxidative Stress
- Metabolic Regulation by Nuclear Receptors
- Fighting Fire with Fire in Cancer
- Linear Polyubiquitination: a Crucial Regulator of NF-kB Activation
- VCP, a major ATPase in the cells, as a novel drug target for currently incurable disorders
- Roles of E-cadherin in hepatocarcinogenesis
- The hippo signaling pathway: a candidate new drug target for malignant tumors
- Inhibitory immunoreceptors on mast cells in allergy and inflammation
- Doxycycline-inducible Autoimmune Blistering Skin Disease Model
- T-cell Senescence and Autoimmunity
- Part II: Translational research for innovative medicine. IL-6: A new era for the treatment of autoimmune inflammatory diseases
- Pathogenesis of Non-alcoholic Steatohepatitis and Its Potential Therapeutic Strategies
- Multifaceted translational approach of major mental illness
- Translational research of leptin in lipodystrophy and its related diseases
- Translational research of the activation of the C-type natriuretic peptide (CNP)-guanylyl cyclase-B pathway for skeletal dysplasia
- Clarity and challenges in tissue fibrosis
- TRP channels: their function and potentiality as drug targets
- Autophagic Cell Death and Cancer Chemotherapeutics
- Adrenomedullin as a potential therapeutic agent for refractory ulcerative colitis
- RNA activation
- Part III: New technology for innovative medicine. Cardiac reprogramming for heart repair
- Development of a new in vivo optical probe for biological diagnosis and therapy
- Introduction of mesenchymal stem cells for liver surgery (hepatectomy and transplantation)
- Synaptic and axonal plasticity induction in the human cerebral cortex
- TIM-3 is a novel therapeutic target for eradicating acute myelogenous leukemia stem cells
- TGF-beta LAP degradation products, a novel biomarker and promising therapeutic target for liver fibrogenesis
- Cell-based regenerative therapy for liver disease.